The role of artificial intelligence in cardiovascular research: Fear less and live bolder

IF 3.6 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

European Journal of Clinical Investigation Pub Date : 2025-04-07 DOI:10.1111/eci.14364

Alessandro Scuricini, Davide Ramoni, Luca Liberale, Fabrizio Montecucco, Federico Carbone

{"title":"The role of artificial intelligence in cardiovascular research: Fear less and live bolder","authors":"Alessandro Scuricini, Davide Ramoni, Luca Liberale, Fabrizio Montecucco, Federico Carbone","doi":"10.1111/eci.14364","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Artificial intelligence (AI) has captured the attention of everyone, including cardiovascular (CV) clinicians and scientists. Moving beyond philosophical debates, modern cardiology cannot overlook AI's growing influence but must actively explore its potential applications in clinical practice and research methodology.</p>\n </section>\n \n <section>\n \n <h3> Methods and Results</h3>\n \n <p>AI offers exciting possibilities for advancing CV medicine by uncovering disease heterogeneity, integrating complex multimodal data, and enhancing treatment strategies. In this review, we discuss the innovative applications of AI in cardiac electrophysiology, imaging, angiography, biomarkers, and genomic data, as well as emerging tools like face recognition and speech analysis. Furthermore, we focus on the expanding role of machine learning (ML) in predicting CV risk and outcomes, outlining a roadmap for the implementation of AI in CV care delivery. While the future of AI holds great promise, technical limitations and ethical challenges remain significant barriers to its widespread clinical adoption.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Addressing these issues through the development of high-quality standards and involving key stakeholders will be essential for AI to transform cardiovascular care safely and effectively.</p>\n </section>\n </div>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":"55 S1","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/eci.14364","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/eci.14364","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Artificial intelligence (AI) has captured the attention of everyone, including cardiovascular (CV) clinicians and scientists. Moving beyond philosophical debates, modern cardiology cannot overlook AI's growing influence but must actively explore its potential applications in clinical practice and research methodology.

Methods and Results

AI offers exciting possibilities for advancing CV medicine by uncovering disease heterogeneity, integrating complex multimodal data, and enhancing treatment strategies. In this review, we discuss the innovative applications of AI in cardiac electrophysiology, imaging, angiography, biomarkers, and genomic data, as well as emerging tools like face recognition and speech analysis. Furthermore, we focus on the expanding role of machine learning (ML) in predicting CV risk and outcomes, outlining a roadmap for the implementation of AI in CV care delivery. While the future of AI holds great promise, technical limitations and ethical challenges remain significant barriers to its widespread clinical adoption.

Conclusions

Addressing these issues through the development of high-quality standards and involving key stakeholders will be essential for AI to transform cardiovascular care safely and effectively.

Abstract Image

查看原文本刊更多论文

人工智能在心血管研究中的作用：少恐惧，活得更大胆

人工智能（AI）已经引起了包括心血管（CV）临床医生和科学家在内的所有人的关注。超越哲学辩论，现代心脏病学不能忽视人工智能日益增长的影响力，但必须积极探索其在临床实践和研究方法中的潜在应用。方法和结果人工智能通过揭示疾病异质性、整合复杂的多模式数据和改进治疗策略，为推进心血管医学提供了令人兴奋的可能性。在这篇综述中，我们讨论了人工智能在心脏电生理、成像、血管造影、生物标志物和基因组数据方面的创新应用，以及人脸识别和语音分析等新兴工具。此外，我们关注机器学习（ML）在预测心血管风险和结果方面的作用，概述了人工智能在心血管护理服务中的实施路线图。虽然人工智能的未来充满希望，但技术限制和伦理挑战仍然是其广泛临床应用的重大障碍。通过制定高质量标准和让关键利益相关者参与来解决这些问题，对于人工智能安全有效地改变心血管护理至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Clinical Investigation 医学-医学：内科

CiteScore

9.50

自引率

3.60%

发文量

192

审稿时长

1 months

期刊介绍： EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.